Yoko Watanabe

1.1k total citations
37 papers, 846 citations indexed

About

Yoko Watanabe is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Yoko Watanabe has authored 37 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Physiology and 6 papers in Biochemistry. Recurrent topics in Yoko Watanabe's work include Amino Acid Enzymes and Metabolism (4 papers), Metabolism and Genetic Disorders (4 papers) and Gastroesophageal reflux and treatments (3 papers). Yoko Watanabe is often cited by papers focused on Amino Acid Enzymes and Metabolism (4 papers), Metabolism and Genetic Disorders (4 papers) and Gastroesophageal reflux and treatments (3 papers). Yoko Watanabe collaborates with scholars based in Japan and United States. Yoko Watanabe's co-authors include Akitane Mori, Kazunari Tominaga, Kazuhide Higuchi, Yasuhiro Fujiwara, Nobuhide Oshitani, Tetsuo Arakawa, Toshio Watanabe, Masatsugu Shiba, Seijiro Honma and Kouwa Yamashita and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Yoko Watanabe

35 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Watanabe Japan 15 269 250 188 118 113 37 846
Huw Davies United Kingdom 14 229 0.9× 158 0.6× 514 2.7× 245 2.1× 50 0.4× 27 1.1k
E. Fellenius Sweden 22 558 2.1× 339 1.4× 504 2.7× 210 1.8× 114 1.0× 48 1.6k
Peter Schadewaldt Germany 22 98 0.4× 108 0.4× 572 3.0× 424 3.6× 104 0.9× 70 1.4k
Ulf Hannestad Sweden 13 93 0.3× 43 0.2× 152 0.8× 104 0.9× 39 0.3× 21 525
Otto Hansen Denmark 23 638 2.4× 163 0.7× 822 4.4× 211 1.8× 67 0.6× 61 1.8k
Norman W. Carter United States 18 224 0.8× 82 0.3× 456 2.4× 224 1.9× 72 0.6× 28 1.3k
D Russell United States 7 229 0.9× 237 0.9× 583 3.1× 109 0.9× 34 0.3× 12 1.1k
Maria Burian Germany 20 513 1.9× 197 0.8× 235 1.3× 158 1.3× 19 0.2× 58 1.5k
Thomas Q. Garvey United States 13 149 0.6× 102 0.4× 172 0.9× 68 0.6× 14 0.1× 21 629
R. Renner Germany 15 194 0.7× 19 0.1× 246 1.3× 158 1.3× 284 2.5× 42 753

Countries citing papers authored by Yoko Watanabe

Since Specialization
Citations

This map shows the geographic impact of Yoko Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Watanabe more than expected).

Fields of papers citing papers by Yoko Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Watanabe. The network helps show where Yoko Watanabe may publish in the future.

Co-authorship network of co-authors of Yoko Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Watanabe. A scholar is included among the top collaborators of Yoko Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Watanabe. Yoko Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishikawa, Jun, et al.. (2023). Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair. Clinica Chimica Acta. 547. 117456–117456. 5 indexed citations
2.
Hiramatsu, Hidefumi, Souichi Adachi, Katsutsugu Umeda, et al.. (2019). Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia. International Journal of Hematology. 111(2). 303–310. 11 indexed citations
3.
Kanamaru, Takuya, et al.. (2016). Albuminuria predicts early neurological deterioration in patients with acute ischemic stroke. Journal of the Neurological Sciences. 372. 417–420. 25 indexed citations
4.
Kaneko, Tomohiro, et al.. (2015). Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine. International Urology and Nephrology. 47(11). 1823–1830. 2 indexed citations
5.
Suda, Satoshi, Toshiya Katsumata, Seiji Okubo, et al.. (2013). Low Serum n-3 Polyunsaturated Fatty Acid/n-6 Polyunsaturated Fatty Acid Ratio Predicts Neurological Deterioration in Japanese Patients with Acute Ischemic Stroke. Cerebrovascular Diseases. 36(5-6). 388–393. 29 indexed citations
6.
Watanabe, Yoko, et al.. (2011). Correlation between Proteinuria and the Condition of Patients with Acute Ischemic Stroke. Journal of Nippon Medical School. 78(6). 410–411.
7.
Kusuda, Satoshi, et al.. (2010). Ovarian cycle approach by rectal temperature and fecal progesterone in a female killer whale, Orcinus orca. Zoo Biology. 30(3). 285–295. 9 indexed citations
8.
Arai, Seiji, Yoshimichi Miyashiro, Yasuhiro Shibata, et al.. (2009). New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography–tandem mass spectrometry. Steroids. 75(1). 13–19. 24 indexed citations
9.
Kaneshiro, Edna S., et al.. (2007). Bacteriovorax stolpii proliferation and predation without sphingophosphonolipids. Biochemical and Biophysical Research Communications. 367(1). 21–25. 6 indexed citations
10.
11.
Fujiwara, Yasuhiro, Kazuhide Higuchi, Masatsugu Shiba, et al.. (2005). Differences in Clinical Characteristics between Patients with Endoscopy-Negative Reflux Disease and Erosive Esophagitis in Japan. The American Journal of Gastroenterology. 100(4). 754–758. 82 indexed citations
12.
Fujiwara, Yasuhiro, Yoko Watanabe, Masatsugu Shiba, et al.. (2005). Association Between Dinner-to-Bed Time and Gastro-Esophageal Reflux Disease. The American Journal of Gastroenterology. 100(12). 2633–2636. 91 indexed citations
13.
Fujiwara, Yasuhiro, Kazuhide Higuchi, Yoko Watanabe, et al.. (2004). Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. Journal of Gastroenterology and Hepatology. 20(1). 26–29. 96 indexed citations
14.
Watanabe, Yoko, John F. Van Pilsum, Isao Yokoi, & Akitane Mori. (1994). Synthesis of neuroactive guanidino compounds by rat kidney L-Arginine: Glycine amidinotrasferase. Life Sciences. 55(5). 351–358. 26 indexed citations
15.
Watanabe, Yoko, et al.. (1991). Effect of guanidinoethanesulfonic acid on brain monoamines in the mouse. Neurochemical Research. 16(10). 1149–1154. 3 indexed citations
16.
Watanabe, Yoko, et al.. (1988). Identification of 1-guanidino-2-(4-imidazole) propionic acid in human urine by high-performance liquid chromatography and field desorption mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 425(2). 373–378. 7 indexed citations
17.
Watanabe, Yoko, et al.. (1988). Formation of 2-guanidinoethanol by a transamidination reaction from arginine and ethanolamine by the rat kidney and pancreas. Life Sciences. 43(4). 295–302. 11 indexed citations
18.
Watanabe, Yoko, Isao Yokoi, & Akitane Mori. (1987). The biosynthesis of 2-guanidinoethanol in intact mice and isolated perfused rabbit kidneys. Life Sciences. 40(3). 293–299. 5 indexed citations
19.
Mori, Akitane, et al.. (1982). α-Guanidinoglutaric Acid and Epilepsy. Advances in experimental medicine and biology. 153. 419–426. 8 indexed citations
20.
Watanabe, Yoko, et al.. (1981). Lymphoblastoid cell lines, transformed by Epstein-Barr virus, in the enzymatic study of hereditary lysosomal storage diseases.. The Tohoku Journal of Experimental Medicine. 134(3). 229–243. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huw Davies Breakdown of academic impact, for papers by E. Fellenius Breakdown of academic impact, for papers by Peter Schadewaldt Breakdown of academic impact, for papers by Ulf Hannestad Breakdown of academic impact, for papers by Otto Hansen Breakdown of academic impact, for papers by Norman W. Carter Breakdown of academic impact, for papers by D Russell Breakdown of academic impact, for papers by Maria Burian Breakdown of academic impact, for papers by Thomas Q. Garvey Breakdown of academic impact, for papers by R. Renner
Rankless by CCL
2026